The U.S. Centers for Disease Control and Prevention is warning communities of color are far less likely to benefit from potentially life-saving treatments for COVID-19. A CDC study released Thursday found African American and Latinx patients received the antiviral drug Paxlovid more than 30% less often than white patients — even though people of color in the U.S. are about twice as likely to be hospitalized with COVID. This comes as U.S. coronavirus hospitalizations have begun to increase for the first time since July.